 Subcutaneous metoclopramide treatment symptomatic gastroparesis clinical efficacy pharmacokinetics safety efficacy short-term administration metoclopramide treatment symptomatic gastric stasis patients gastroparesis abnormal solid phase radionuclide gastric study mg ml metoclopramide hr days Patients injections outpatients Questionnaires symptom relief local side effects adverse reactions repeat gastric study last dose metoclopramide Serum metoclopramide concentrations trough hr postadministration serum prolactin levels trough hr Pharmacokinetic analysis mean peak metoclopramide concentration min ng/ml measured levels ng/ml min return values hr prolactins elevated normal values Gastric stasis base-line retention radioisotope hr days therapy patients significant improvement symptomology patients lessening symptoms nausea bloating abdominal pain heartburn vomiting side effects minimal completion protocol administration metoclopramide patients subjective objective improvement gastric stasis addition serum metoclopramide concentrations comparable parenteral routes administration serum prolactin levels bioassay efficacy marker compliance